Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft
Oslo, Norway, 9 December 2022
Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) announces that it has entered into a long-term industrial energy agreement with Statkraft, the leading Norwegian energy supplier. The agreement will secure a significant part of Vistin’s electricity demand on competitive terms until 2032. The agreement includes Guarantees of Origin as certification of the renewable energy supply, and starts 1.1.2023.
2022 has been very challenging for Vistin and the Norwegian industry, when it comes to electricity costs, with extreme volatility and record high electricity prices in the NO2 area where Vistin’s fully automated production plant is located.
- This agreement will give Vistin Pharma stable electricity supply at predictable and competitive prices. The agreement helps to secure our competitiveness in the global Metformin market. We are happy that Statkraft by this agreement contributes to the future development of Vistin and therebyallows the company to continue focusing on its growth strategy,says Kjell-Erik Nordby, CEO in Vistin Pharma.
- We are very pleased to conclude another renewable energy contract with the Norwegian industry which confirms that Statkraft offers relevant solutions at competitive terms, says Frode Berntsen, Head of Industry Nordics & Baltics at Statkraft.
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.
About Statkraft | www.statkraft.com
Statkraft is a leading company in hydropower internationally and Europe's largest generator of renewable energy. The Group produces hydropower, wind power, solar power, gas-fired power and supplies district heating. Statkraft is a global company in energy market operations Statkraft has 4,800 employees in 20 countries.
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May25.4.2024 07:00:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 25, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May 2023 financial key figures: Revenue from contracts with customers of CHF 103.4 million (2022: CHF 7.5 million) Net result of CHF 54.8 million (2022: CHF -71.1 million) Cash flow from operating activities of CHF 47.6 million (2022: CHF -29.8 million)Regulatory approvals in key territories – AGAMREE® (vamorolone) approved for Duchenne muscular dystrophy (DMD) treatment in the U.S., EU and UK, showcasing safety benefits over traditional corticosteroidsStrategic partnership – licensing agreement signed with Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) for North America, focusing on commercialization of AGAMREE in DMD and exploring joint development of indications beyond DMDFirst launches
Verkkokauppa.com focused on profitability in a declining market25.4.2024 07:00:00 CEST | Press release
INTERIM REPORT for 1 January – 31 March 2024 VERKKOKAUPPA.COM FOCUSED ON PROFITABILITY IN A DECLINING MARKET Verkkokauppa.com Oyj INTERIM REPORT 25 April 2024, 8:00 a.m. EEST Verkkokauppa.com arranges two virtual news conferences on a result publication day. The news conference in Finnish will be held at 10:00 am Finnish time. The news conference for analysts and institutional investors in English will be at 11:00 am Finnish time. Details of the events and how to participate can be found at the end of this release. This is a summary of Verkkokauppa.com’s Financial Statements Review for 1 January – 31 December 2023. The complete report is attached to this release and also available at https://investors.verkkokauppa.com/en Unless otherwise stated, the comparison figures in brackets refer to the corresponding period in the previous year (reference period). Figures are unaudited. January – March 2024 in brief Revenue was EUR 108.0 million (122.0)Gross profit was EUR 18.7 million (20.2) or
Kitron: Q1 2024 - Sterk underliggende lønnsomhet i utfordrende marked25.4.2024 07:00:00 CEST | Pressemelding
(2024-04-25) Kitron rapporterer i dag sterk underliggende lønnsomhet i et utfordrende marked. Det gjennomføres kostnadstiltak for å opprettholde driftsmarginer i tråd med selskapets strategiske mål. Kitrons driftsinntekter for første kvartal var 173,9 millioner euro, sammenlignet med 190,6 millioner i fjor. Det var sterk vekst innenfor markedssektoren Forsvar/Luftfart, mens andre markedssektorer viste nedgang. Driftsresultatet (EBIT) i første kvartal var 10,6 millioner euro, sammenlignet med 17,3 millioner i fjor. EBITDA ble 15,2 millioner euro, mot 21,4 millioner i fjor. Resultatet er påvirket av restruktureringskostnader på 4,8 millioner euro. Lønnsomheten uttrykt som EBIT-margin var 6,1 prosent, inkludert restruktureringskostnadene, mot 9,1 prosent i fjor. Lønnsomheten justert for restruktureringskostnader var 8,8 prosent. Ordrereserven endte på 445 millioner euro, en nedgang på 24 prosent sammenlignet med fjoråret og en nedgang på 10 prosent fra foregående kvartal. Peter Nilsson, K
SIKA OPENS MACROFIBER PRODUCTION HUB IN PERU TO MEET FAST-GROWING DEMAND IN LATIN AMERICA25.4.2024 07:00:00 CEST | Press release
SIKA OPENS MACROFIBER PRODUCTION HUB IN PERU TO MEET FAST-GROWING DEMAND IN LATIN AMERICA Sika is opening a state-of-the-art facility in Lima, Peru, to produce synthetic macro fibers, and expanding the rollout of a product range with great growth potential in Latin America. With this innovative technology, Sika is further strengthening its position as a leading supplier to the mining industry and a strong partner for infrastructure projects. Synthetic macro fibers are based on an advanced technology for the constructive and static reinforcement of concrete structures. They reduce construction time and costs by eliminating the need to install conventional reinforcement, while improving the properties of cured concrete. In addition, this innovative technology significantly extends the concrete structures' lifespan compared to steel reinforcement. These factors have a positive sustainability impact on green building ratings such as the international LEED certification system. Mike Campion
Sp Mortgage Bank Plc & Savings Banks Group: Half-Year Reports for January–June 2024 will be published on 14 August 202425.4.2024 07:00:00 CEST | Press release
Stock Exchange Release 25th of April 2024 at 8 am (CET +1) Sp Mortgage Bank Plc & Savings Banks Group: Half-Year Reports for 1st of January–30th of June 2024 will be published on 14th of August 2024 as a stock exchange release and can be also found at www.saastopankki.fi. Sp Mortgage Bank Plc & Savings Banks Group Further information: Karri Alameri Managing Director, Savings Banks Union Coop karri.alameri@saastopankki.fi +358 45 656 5250 Sp Mortgage Bank Plc is part of the Savings Banks Group and the Savings Banks Amalgamation. The role of Sp Mortgage Bank is, together with Central Bank of Savings Banks Finland Plc, to be responsible for obtaining funding for the Savings Banks Group from money and capital markets. Sp Mortgage Bank is responsible for the Savings Banks Group's mortgage-secured funding by issuing covered bonds.